echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Shanghai Pharmaceuticals Pregabalin Capsules Received U.S. FDA Approval Number

    Shanghai Pharmaceuticals Pregabalin Capsules Received U.S. FDA Approval Number

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Shanghai Pharmaceuticals issued an announcement stating that its subsidiary, Changzhou Pharmaceutical Factory Co.


    Pregabalin capsules are mainly used to treat post-herpetic neuralgia, diabetic peripheral neuralgia, fibromyalgia, neuropathic pain caused by spinal cord injury, and adjuvant therapy for epilepsy


    As of the disclosure date of this announcement, the drug has invested approximately RMB 7.


    Pregabalin capsules original research plant for Pfizer, overseas production and sales of manufacturers are Actavis, Teva, Dr.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.